Endometriosis and the neoplastic process
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Endometriosis is a frequent disorder that commonly presents with infertility and pelvic pain. Although the precise aetiology of endometriosis is unclear, it is generally considered to involve multiple genetic, environmental, immunological, angiogenic and endocrine processes. Genetic factors have been implicated in endometriosis but the susceptibility genes remain largely unknown. Although endometriosis is a benign disorder, recent studies of endometriosis suggest endometriosis could be viewed as a neoplastic process. Evidence to support this hypothesis includes the increased susceptibility to develop ovarian clear-cell and endometrioid cancers in the presence of endometriosis, and molecular similarities between endometriosis and cancer. In this article we discuss (i) the evidence suggesting that endometriosis might be viewed as a neoplastic process, and (ii) the implications of this hypothesis for elucidating the pathogenesis of endometriosis and developing novel methods of diagnostic classification and individualised treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“The classic model of malignant transformation of the cell involves the stepwise acquisition of multiple genetic alterations, which confers a clonal selective advantage at each step, predisposing to the next step (Lengauer et al. 1998).”
BackgroundImmunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857 · cited 1×
“Other growth factors, such as transforming growth factor-a and insulin-like growth factor-I (IGF-I) have also been implicated in endometriosis and cancer development (Lebovic et al. 2001).”
BackgroundENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN
SAMPSON, J. A. (1925) · Archives of Surgery · doi:10.1001/archsurg.1925.01120100007001 · Cited by 765
Kao, L. C., Germeyer, A., Tulac, S., Lobo, S., Yang, J. P., Taylor, R. N., Osteen, K., Lessey, B. A., & Giudice, L. C. (2003) · Endocrinology · doi:10.1210/en.2003-0043 · Cited by 696
Ovarian atypical endometriosis: its close association with malignant epithelial tumours
FUKUNAGA, M., NOMURA, K., ISHIKAWA, E., & USHIGOME, S. (1997) · Histopathology · doi:10.1046/j.1365-2559.1997.d01-592.x · Cited by 333 · cited 5×
“Furthermore, the histology of EAOC (40–55% clearcell, 20–40% endometrioid and ,10% serous and mucinous subtypes) (Fukunaga et al. 1997, Yoshikawa et al. 2000, Modesitt et al. 2002) differs considerably from that seen in all ovarian cancers (FIGO 1998 annual report 55% serous, 13% mucinous, 14%…”
BackgroundInfluentialOgawa, S., Kaku, T., Amada, S., Kobayashi, H., Hirakawa, T., Ariyoshi, K., Kamura, T., & Nakano, H. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5765 · Cited by 279 · cited 2×
“Around 60–80% of cases of endometriosis-associated ovarian cancer (EAOC) occur in the presence of atypical ovarian endometriosis (Fukunaga et al. 1997, Ogawa et al. 2000, Oral et al. 2003).”
BackgroundOvarian and extraovarian endometriosis-associated cancer
Modesitt, S. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02149-x · Cited by 242 · cited 6×
“The different pattern of expression in the two groups suggests different molecular pathways and could explain variations in cancer subtype and prognosis between the two groups (Erzen et al. 2001, Modesitt et al. 2002).”
BackgroundInfluentialProgesterone Receptor Isoform A But Not B Is Expressed in Endometriosis1
Attia, G. R., Zeitoun, K., Edwards, D., Johns, A., Carr, B. R., & Bulun, S. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6739 · Cited by 193
Eržen, M., Rakar, S., Klančar, B., & Syrjänen, K. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6382 · Cited by 160 · cited 2×
“…matched ovarian cancer subtypes not associated with endometriosis EAOC compared with ovarian cancer without endometriosis, presents at a less-advanced stage, lower grade, predominantly endometrioid and clear-cell type, and has a better overall survival (Erzen et al. 2001, Modesitt et al. 2002).”
BackgroundExpression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis
Matsuzaki, S., Murakami, T., Uehara, S., Canis, M., Sasano, H., & Okamura, K. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01783-6 · Cited by 133
Cited by
The search for genes contributing to endometriosis risk
Montgomery, G. W., Nyholt, D. R., Zhao, Z. Z., Treloar, S. A., Painter, J. N., Missmer, S. A., Kennedy, S. H., & Zondervan, K. T. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn016 · Cited by 211
Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer
Suryawanshi, S., Vlad, A. M., Lin, H.-M., Mantia-Smaldone, G., Laskey, R., Lee, M., Lin, Y., Donnellan, N., Klein-Patel, M., Lee, T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2726 · Cited by 197
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors
Brinton, L. A., Sakoda, L. C., Sherman, M. E., Frederiksen, K., Kjaer, S. K., Graubard, B. I., Olsen, J. H., & Mellemkjaer, L. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0394 · Cited by 166
Yamamoto, S., Tsuda, H., Takano, M., Iwaya, K., Tamai, S., & Matsubara, O. (2011) · The Journal of Pathology · doi:10.1002/path.2940 · Cited by 152
Endometriosis-associated Malignancy
Krawczyk, N., Banys-Paluchowski, M., Schmidt, D., Ulrich, U., & Fehm, T. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0035-1558239 · Cited by 107
“Several studies have demonstrated that microenvironment of endometriosis and EAOC share similar mediators and cytokines [40, 41].”
Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis
Becker, C. M., Beaudry, P., Funakoshi, T., Benny, O., Zaslavsky, A., Zurakowski, D., Folkman, J., D'Amato, R. J., & Ryeom, S. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.037 · Cited by 81
“5,6 In addition, patients with endometriosis have an increased risk of ovarian cancer and non-Hodgkin’s lymphoma, 7,8 which adds to the burden of the disease.”
BackgroundHormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer
Melin, A., Lundholm, C., Malki, N., Swahn, M., Sparèn, P., & Bergqvist, A. (2013) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12123 · Cited by 75
“interleukin-1, interleukin-8, interleukin-6, tumor necrosis factor-a and tumor necrosis factor-b) are involved in endometriosis as well as in ovarian cancer development (29,31,32).”
BackgroundInsights into assessing the genetics of endometriosis
Rahmioglu, N., Missmer, S. A., Montgomery, G. W., & Zondervan, K. T. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-012-0016-5 · Cited by 71
“…and growth of endometriotic lesions in only some women include increased exposure to menstrual debris (e.g., increased menstrual flow, shorter cycle length), abnormal eutopic endometrium, altered peritoneal environment, reduced immune surveillance, and increased angiogenic capacity [9 – 11].”
BackgroundHormone replacement therapy in women with past history of endometriosis
Soliman, N. F., & Hillard, T. C. (2006) · Climacteric · doi:10.1080/13697130600868711 · Cited by 65
Transformation maligne d’une endométriose pariétale
Sergent, F., Baron, M., Le Cornec, J.-B., Scotté, M., Mace, P., & Marpeau, L. (2006) · Journal de Gynécologie Obstétrique et Biologie de la Reproduction · doi:10.1016/s0368-2315(06)76394-3 · Cited by 57
Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: A meta-analysis
li, J., Liu, R., Tang, S., Feng, F., Liu, C., Wang, L., Zhao, W., Zhang, T., Yao, Y., Wang, X., et al. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4968-1 · Cited by 56
Taniguchi, F., Harada, T., Kobayashi, H., Hayashi, K., Momoeda, M., & Terakawa, N. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000357819 · Cited by 31
Clear Cell Adenocarcinoma Arising from Abdominal Wall Endometriosis
Achach, T., Rammeh, S., Trabelsi, A., Ltaief, R., Ben Abdelkrim, S., Mokni, M., & Korbi, S. (2008) · Journal of Oncology · doi:10.1155/2008/478325 · Cited by 26
“There is extensive clinicopathological, molecular, and genetic evidence supporting the hypothesis that endometriosis is a neoplastic process with a potential for malignant transformation [3].”
Background
Metadata
- Authors
- Varma, R., Rollason, T., Gupta, J. K., & Maher, E. R.
- Venue
- Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 127
- Issue
- 3
- Pages
- 293-304
- ISSN
- 1470-1626 (ISSN-L)
- 1741-7899
- OpenAlex
- W2127152095
- Cited by
- 214
- References
- 13
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.